NCT02061995View on ClinicalTrials.gov

Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Severe Osteoporosis
Interventions
DRUG

PREOB® Intravenous Infusion

Each patient will undergo a single intravenous administration of PREOB®.

Trial Locations (1)

Unknown

Investigating site BE01, Anderlecht

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT02061995 - Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis | Biotech Hunter | Biotech Hunter